Review shows cardiac MRI effectively identifies amyloidosis in patients with heart failure, implying accurate diagnosis.
Cardiac amyloidosis is characterized by extracellular deposition of abnor- mal proteins in the myocardium. A manifestation of cardiac amy- loidosis is the rapid progression of heart failure and the development of life-threatening arrhythmias, atrial fibrillation, and embolic strokes. The diagnosis of cardiac amyloidosis should be excluded in all patients with rapidly progressive heart failure associated with a restrictive remodeling phenotype in combination with myocardial hypertrophy. Cardiac magnetic resonance imaging (MRI) is considered to be an accurate and specific diagnostic method. This article reviews the diagnostic MR-criteria for cardiac amyloidosis and provides confirmed clinical cases.
No takes yet. Share an insight, caveat, or question.
Model et al. (2025) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: